These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21505144)

  • 1. Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.
    She P; Zhang Z; Marchionini D; Diaz WC; Jetton TJ; Kimball SR; Vary TC; Lang CH; Lynch CJ
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E49-61. PubMed ID: 21505144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle atrophy in R6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.
    Magnusson-Lind A; Davidsson M; Silajdžić E; Hansen C; McCourt AC; Tabrizi SJ; Björkqvist M
    J Huntingtons Dis; 2014; 3(1):13-24. PubMed ID: 25062762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease.
    Sjögren M; Duarte AI; McCourt AC; Shcherbina L; Wierup N; Björkqvist M
    Sci Rep; 2017 Oct; 7(1):13896. PubMed ID: 29066728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.
    Wu BT; Chiang MC; Tasi CY; Kuo CH; Shyu WC; Kao CL; Huang CY; Lee SD
    Cardiovasc Toxicol; 2016 Apr; 16(2):111-21. PubMed ID: 25800750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia.
    Desgeorges MM; Devillard X; Toutain J; Divoux D; Castells J; Bernaudin M; Touzani O; Freyssenet DG
    Stroke; 2015 Jun; 46(6):1673-80. PubMed ID: 25953371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balanced Diet-Fed Fat-1 Transgenic Mice Exhibit Lower Hindlimb Suspension-Induced Soleus Muscle Atrophy.
    Marzuca-Nassr GN; Murata GM; Martins AR; Vitzel KF; Crisma AR; Torres RP; Mancini-Filho J; Kang JX; Curi R
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28984836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin.
    Ehrnhoefer DE; Skotte NH; Ladha S; Nguyen YT; Qiu X; Deng Y; Huynh KT; Engemann S; Nielsen SM; Becanovic K; Leavitt BR; Hasholt L; Hayden MR
    Hum Mol Genet; 2014 Feb; 23(3):717-29. PubMed ID: 24070868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.
    Sjögren M; Soylu-Kucharz R; Dandunna U; Stan TL; Cavalera M; Sandelius Å; Zetterberg H; Björkqvist M
    Neurobiol Dis; 2019 Dec; 132():104560. PubMed ID: 31419548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.
    Bondulich MK; Jolinon N; Osborne GF; Smith EJ; Rattray I; Neueder A; Sathasivam K; Ahmed M; Ali N; Benjamin AC; Chang X; Dick JRT; Ellis M; Franklin SA; Goodwin D; Inuabasi L; Lazell H; Lehar A; Richard-Londt A; Rosinski J; Smith DL; Wood T; Tabrizi SJ; Brandner S; Greensmith L; Howland D; Munoz-Sanjuan I; Lee SJ; Bates GP
    Sci Rep; 2017 Oct; 7(1):14275. PubMed ID: 29079832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Molecular Signaling Signatures of Muscle Protein Wasting Between the Intercostal Muscles and the Gastrocnemius Muscles in
    Kim KW; Baek MO; Choi JY; Son KH; Yoon MS
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31805681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia impairs adaptation of skeletal muscle protein turnover- and AMPK signaling during fasting-induced muscle atrophy.
    de Theije CC; Schols AMWJ; Lamers WH; Neumann D; Köhler SE; Langen RCJ
    PLoS One; 2018; 13(9):e0203630. PubMed ID: 30212583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
    Dufour BD; McBride JL
    Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease.
    Rodinova M; Krizova J; Stufkova H; Bohuslavova B; Askeland G; Dosoudilova Z; Juhas S; Juhasova J; Ellederova Z; Zeman J; Eide L; Motlik J; Hansikova H
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31278192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia.
    Springer J; Schust S; Peske K; Tschirner A; Rex A; Engel O; Scherbakov N; Meisel A; von Haehling S; Boschmann M; Anker SD; Dirnagl U; Doehner W
    Stroke; 2014 Dec; 45(12):3675-83. PubMed ID: 25352483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals.
    Segalés J; Perdiguero E; Serrano AL; Sousa-Victor P; Ortet L; Jardí M; Budanov AV; Garcia-Prat L; Sandri M; Thomson DM; Karin M; Hee Lee J; Muñoz-Cánoves P
    Nat Commun; 2020 Jan; 11(1):189. PubMed ID: 31929511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms Underlying Muscle Wasting in Huntington's Disease.
    Bozzi M; Sciandra F
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of polyglutamine inclusions in non-CNS tissue.
    Sathasivam K; Hobbs C; Turmaine M; Mangiarini L; Mahal A; Bertaux F; Wanker EE; Doherty P; Davies SW; Bates GP
    Hum Mol Genet; 1999 May; 8(5):813-22. PubMed ID: 10196370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.